[RGLS] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
02-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -2.57%
YoY- -177.06%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 18 18 18 18 10,860 4,219 5,454 -61.39%
PBT -4,893 -8,502 -14,506 -20,015 -7,222 -22,168 -1,946 16.60%
Tax -131 61 -58 5 4 -1 -19 37.93%
NP -4,893 -8,563 -14,448 -20,020 -7,226 -22,168 -1,927 16.79%
Tax Rate - - - - - - - -
Total Cost 4,911 8,581 14,466 20,038 18,086 26,387 7,381 -6.56%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -27,183.33 -47,572.22 -80,266.67 -111,222.22 -66.54 -525.43 -35.33 202.55%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -2.34 -9.75 -16.68 -45.39 -16.52 -56.76 -5.53 -13.34%
EPS Diluted -2.34 -9.75 -16.68 -45.39 -16.52 -56.76 -5.35 -12.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.